Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Synthesis and Regulation of Thyroid Hormones01:20

Synthesis and Regulation of Thyroid Hormones

5.1K
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
5.1K
Regulation of Hormone Secretion01:19

Regulation of Hormone Secretion

4.0K
Regulation of hormone secretion is a finely tuned orchestration driven by various types of stimuli, encompassing neural, humoral, and hormonal signals. Environmental cues instigate neural stimuli, where action potentials traverse nerve fibers to reach their designated targets. An illustrative scenario is the body's response to stress, wherein the sympathetic nervous system releases epinephrine from the adrenal glands, inducing the well-known 'fight or flight' reaction.
Humoral...
4.0K
Functions of Thyroid Hormones01:18

Functions of Thyroid Hormones

3.1K
The thyroid hormone (TH) plays a pivotal role in the intricate orchestration of physiological processes, exerting profound effects on development, metabolism, and homeostasis throughout different life stages.
TH is indispensable for the normal development and maturation of the skeletal, muscular, and nervous systems during fetal and childhood growth. It facilitates bone mineral turnover and regulates protein synthesis in developing tissues, contributing significantly to overall growth and...
3.1K
Hormonal Control of the Ovarian Cycle01:30

Hormonal Control of the Ovarian Cycle

2.6K
The ovarian cycle is meticulously regulated by the hypothalamic-pituitary-gonadal axis. This cycle orchestrates the release of a mature oocyte, essential for reproduction.
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle.  At puberty, GnRH secretion increases in both frequency and...
2.6K
Target Cell Response to Hormones01:22

Target Cell Response to Hormones

3.5K
Hormones intricately bind to receptors on the surface or within target cells, initiating a cascade of cellular responses.
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
3.5K
Hormonal Regulation01:40

Hormonal Regulation

44.1K
Hormones regulate a significant portion of digestion through activation of the neuroendocrine system. The neuroendocrine system of digestion contains many different hormones all with multiple functions that are both, directly and indirectly, involved in digestion.
44.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical and Biochemical Monitoring of Monocarboxylate Transporter 8 Deficiency (Allan-Herndon-Dudley Syndrome) across the Lifespan: Practical Considerations for Multidisciplinary Care.

Hormone research in paediatrics·2026
Same author

Editorial: Mechanistic, machine learning and hybrid models of the 'other' endocrine regulatory systems in health and disease, volume II.

Frontiers in endocrinology·2026
Same author

Thyrotoxicosis in MCT8 deficiency.

The Journal of clinical endocrinology and metabolism·2026
Same author

Endotyping Insulin-Glucose Homeostasis in Hidradenitis Suppurativa: The Impact of Diabetes Mellitus and Inflammation.

Journal of clinical medicine·2025
Same author

Informed circular fields: a global reactive obstacle avoidance framework for robotic manipulators.

Frontiers in robotics and AI·2025
Same author

Model Predictive Temperature Control for Retinal Laser Treatments.

Translational vision science & technology·2024

Related Experiment Video

Updated: Sep 5, 2025

Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies
06:24

Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies

Published on: January 10, 2025

915

Optimal Hormone Replacement Therapy in Hypothyroidism - A Model Predictive Control Approach.

Tobias M Wolff1, Johannes W Dietrich2,3,4, Matthias A Müller1

  • 1Institute of Automatic Control, Leibniz University Hannover, Hannover, Germany.

Frontiers in Endocrinology
|July 11, 2022
PubMed
Summary

Developing optimal thyroid hormone replacement strategies is crucial for hypothyroidism. This study suggests combined liothyronine/levothyroxine therapy may be superior, with specific genetic variations influencing the best approach.

Keywords:
automatic controlcombined therapymathematical modelingmodel predictive controlmonotherapythyroid homeostasis

More Related Videos

Generation of Hypoparathyroid Rats via Carbon-Nanoparticle-Assisted Parathyroidectomy
03:57

Generation of Hypoparathyroid Rats via Carbon-Nanoparticle-Assisted Parathyroidectomy

Published on: July 14, 2023

2.0K
Author Spotlight: In Vivo Assessment of Thyroid Hormone Disruption Using the THAI Mouse Model
04:14

Author Spotlight: In Vivo Assessment of Thyroid Hormone Disruption Using the THAI Mouse Model

Published on: October 6, 2023

964

Related Experiment Videos

Last Updated: Sep 5, 2025

Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies
06:24

Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies

Published on: January 10, 2025

915
Generation of Hypoparathyroid Rats via Carbon-Nanoparticle-Assisted Parathyroidectomy
03:57

Generation of Hypoparathyroid Rats via Carbon-Nanoparticle-Assisted Parathyroidectomy

Published on: July 14, 2023

2.0K
Author Spotlight: In Vivo Assessment of Thyroid Hormone Disruption Using the THAI Mouse Model
04:14

Author Spotlight: In Vivo Assessment of Thyroid Hormone Disruption Using the THAI Mouse Model

Published on: October 6, 2023

964

Area of Science:

  • Endocrinology and Metabolism
  • Computational Biology
  • Pharmacology

Background:

  • Hypothyroidism treatment involves managing thyroid hormone levels, often with levothyroxine (L-T4) monotherapy.
  • The optimal strategy, including the use of liothyronine/levothyroxine (L-T3/L-T4) combined therapy and L-T3 intake frequency, remains unclear.
  • Individual patient factors, including genetic variations, may influence treatment efficacy.

Purpose of the Study:

  • To develop an optimal thyroid hormone replacement strategy for hypothyroid patients.
  • To compare the efficacy of L-T4 monotherapy versus L-T3/L-T4 combined therapy.
  • To investigate the impact of genetic polymorphisms on treatment outcomes and determine optimal L-T3 intake frequency.

Main Methods:

  • Extended a mathematical model of the pituitary-thyroid feedback loop to simulate oral L-T3/L-T4 intake.
  • Employed a model predictive controller (MPC) to determine optimal dosages for different therapies.
  • Simulated treatment outcomes for various genetic variants (DIO1 rs2235544, DIO2 rs225014) and intake frequencies.

Main Results:

  • L-T3/L-T4 combined therapy generally showed slightly better hormone concentrations than L-T4 monotherapy.
  • For DIO1 rs2235544 genotype CC, L-T4 monotherapy was suggested as better.
  • For DIO1 rs2235544 genotype AA and DIO2 rs225014 genotype CC, L-T3/L-T4 combined therapy was indicated as more effective.
  • Two daily intakes of L-T3 offered a balance between stable hormone levels and patient convenience.

Conclusions:

  • The choice between L-T4 monotherapy and L-T3/L-T4 combined therapy for hypothyroidism should consider individual genetic profiles.
  • A twice-daily L-T3 dosing regimen may optimize treatment outcomes and patient adherence.
  • Mathematical modeling provides a valuable tool for personalized thyroid hormone replacement therapy development.